These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 2859924
21. A therapeutic trial of maytansine. Blum RH, Wittenberg BK, Canellos GP, Mayer RJ, Skarin AT, Henderson IC, Parker LM, Frei E. Cancer Clin Trials; 1978; 1(2):113-7. PubMed ID: 757139 [Abstract] [Full Text] [Related]
22. Phase II evaluation of maytansine in patients with advanced head and neck cancer. Creagan ET, Fleming TR, Edmonson JH, Ingle JN. Cancer Treat Rep; 1979; 63(11-12):2061-2. PubMed ID: 526939 [No Abstract] [Full Text] [Related]
31. Phase II study of maytansine in advanced sarcomas. Edmonson JH, Hahn RG, Creagan ET, O'Connell MJ. Cancer Treat Rep; 1983 Apr; 67(4):401-2. PubMed ID: 6850657 [No Abstract] [Full Text] [Related]
34. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA, Stroehlein JR, Bennetts RW, Jones RD, Heifetz LJ, Mahal PS. Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [Abstract] [Full Text] [Related]
35. Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group. Van Rijswijk RE, Jeziorski K, Wagener DJ, Van Laethem JL, Reuse S, Baron B, Wils J, EORTC GastroIntestinal Tract Cancer Cooperative Group. Eur J Cancer; 2004 Sep; 40(14):2077-81. PubMed ID: 15341982 [Abstract] [Full Text] [Related]